Free shipping on all orders over $ 500

 About 1 result found for searched term "1000676-41-4" (0.119 seconds)

Cat.No.  Name Target
M24528 Lirilumab Others
IPH2102
Lirilumab (IPH2102) is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.